Back to Portfolio
Panalgo
Delivering real-world evidence-based analytics solutions that answer pharmaceutical firms' toughest questions
Real-world evidence-based analytics software platform used by life science and research organizations worldwide
Executive Chairman
Joe Menzin
CEO
Jordan Menzin
Executive Chairman
Joe Menzin
In the News
View All
Portfolio News
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
Portfolio News
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
Portfolio Perspectives
Panalgo: How Real-World Data Can Help Us Better Prepare for the Next Pandemic
Portfolio Perspectives
Panalgo: How Real-World Data Can Help Us Better Prepare for the Next Pandemic
The companies identified above may not represent all of Silversmith’s investments, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. For a full list of all Silversmith investments, please click here. Further, the list of investments is updated periodically and as such may not reflect most recent Silversmith investments. Certain information included in this site was derived from third-party materials or other sources believed to be accurate, but no independent verification has been made of such materials or other sources. Logos reflected herein are provided for illustrative purposes only and do not represent an endorsement by or an affiliation with such companies or organizations. The views expressed herein are the opinions of third parties and should not be construed as absolute statements and are subject to change without notice to you. No representation, express or implied, is given regarding the accuracy of the information contained herein. Neither the Silversmith nor any of its affiliates has any obligation to update the information contained herein.